Merck CEO leaves Trump’s manufacturing council over Charlottesville response; researchers struggle to fill clinical trials for IO drugs; Roche shareholders sue over top-line results
Five things for pharma marketers to know: Tuesday, July 11, 2017
Trump administration considers outcomes-based approach to lower drug prices; Sanofi to acquire vaccines biotech; Nestle partners with Enterome to develop microbiome-based diagnostics
Five things for pharma marketers to know: Monday, June 19, 2017
Adamis receives FDA approval for EpiPen rival Symjepi; Clovis reports positive trial results for ovarian cancer drug Rubraca; hedge fund billionaire John Paulson joins Valeant board of directors
Five things for pharma marketers to know: Thursday, June 1, 2017
50% of consumers say they will share their health data with tech giants; pharma CEOs expect pricing proposal from Trump administration; FDA approves generic versions of Strattera
Gottlieb Likely to Take On Off-Label, Predictability at the FDA